SCHEMBL30176346

SCHEMBL30176346

Cc1cc(-n2c(C3CC3)c(C(Cc3ccccc3)C(=O)O)c3cc(OCc4ccccc4)ccc32)ccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 2/20 0.42
EDNRB P24530 2/20 0.42
EDNRA P25101 2/20 0.42
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
FFAR1 O14842 3/20 0.38
S1PR1 P21453 1/20 0.37
S1PR5 Q9H228 1/20 0.37
LTB4R Q15722 1/20 0.37
LTB4R2 Q9NPC1 1/20 0.37
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
MCHR1 Q99705 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PLA2G2A P14555 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23886835 1.00 HTR3A (0.42) HTR3AEDNRBEDNRAMEN1NPC1
SCHEMBL30337916 0.94 HTR3A (0.42) HTR3AEDNRBEDNRAMEN1NPC1
SCHEMBL30176263 0.94 HTR3A (0.42) HTR3AEDNRBEDNRAMEN1NPC1
SCHEMBL23886750 0.94 HTR3A (0.42) HTR3AEDNRBEDNRAMEN1NPC1
SCHEMBL30176391 0.89 PLA2G2A (0.40) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL23887040 0.89 PLA2G2A (0.40) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL30176393 0.89 PLA2G2A (0.40) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL28995402 0.85 EDNRB (0.40) HTR3AEDNRBEDNRAMEN1NPC1
SCHEMBL28995426 0.84 PLA2G2A (0.46) EDNRBEDNRAFFAR1LTB4RLTB4R2
SCHEMBL23886720 0.82 PLA2G2A (0.45) HTR3AEDNRBEDNRAMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916749-A Substituted 5-hydroxyindole compounds as alpha-1 antitrypsin modulators 弗特克斯药品有限公司 2023-04-04 CN disclosed
EP-4126817-A1 SUBSTITUTED 5-HYDROXYINDOLE COMPOUNDS AS MODULATORS OF ALPHA-1 ANTITRYPSIN Vertex Pharmaceuticals Incorporated (US) 2023-02-08 EP disclosed